Longbow Finance SA Has $12.72 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Longbow Finance SA boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 25,150 shares of the healthcare conglomerate’s stock after buying an additional 1,191 shares during the quarter. UnitedHealth Group comprises 1.4% of Longbow Finance SA’s portfolio, making the stock its 17th biggest holding. Longbow Finance SA’s holdings in UnitedHealth Group were worth $12,722,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the business. Sterling Investment Advisors Ltd. acquired a new position in UnitedHealth Group during the fourth quarter worth $228,000. Todd Asset Management LLC grew its position in shares of UnitedHealth Group by 1.6% in the fourth quarter. Todd Asset Management LLC now owns 56,816 shares of the healthcare conglomerate’s stock valued at $28,741,000 after purchasing an additional 908 shares during the last quarter. Exchange Capital Management Inc. acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $426,000. Twin Peaks Wealth Advisors LLC grew its position in shares of UnitedHealth Group by 191.9% in the fourth quarter. Twin Peaks Wealth Advisors LLC now owns 1,760 shares of the healthcare conglomerate’s stock valued at $890,000 after purchasing an additional 1,157 shares during the last quarter. Finally, Commonwealth Retirement Investments LLC grew its position in shares of UnitedHealth Group by 1.6% in the fourth quarter. Commonwealth Retirement Investments LLC now owns 10,463 shares of the healthcare conglomerate’s stock valued at $5,293,000 after purchasing an additional 168 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $461.09 on Tuesday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm has a 50 day moving average of $518.52 and a 200-day moving average of $559.70. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $424.33 billion, a P/E ratio of 29.75, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $5.83 earnings per share. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.82%. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.33% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several brokerages have recently issued reports on UNH. Deutsche Bank Aktiengesellschaft raised their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd. Piper Sandler reduced their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. KeyCorp reiterated an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Wells Fargo & Company reduced their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Finally, StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.